Publications
- Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?2022 | First Faculty of Medicine
- Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications2020 | First Faculty of Medicine, Faculty of Science
- Targeting fibroblast activation protein in cancer - Prospects and caveats2018 | First Faculty of Medicine
- Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein2017 | First Faculty of Medicine, Faculty of Science
- Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice2017 | First Faculty of Medicine
- Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas2017 | First Faculty of Medicine
- Annual monitoring of side effects of administering sitagliptin in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Third Faculty of Medicine
- The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Third Faculty of Medicine
- Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma2016 | First Faculty of Medicine
- Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets2015 | First Faculty of Medicine
Loading network view...